Overview

Study Investigating a Delayed-Release Pancrelipase in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis

Status:
Completed

Trial end date:
2008-03-01

Target enrollment:

Participant gender:

Summary

This study will assess the effect of pancrelipase delayed release 24,000 unit capsules on fat and nitrogen absorption in subjects with PEI due to Cystic Fibrosis.

Phase:

Phase 3

Details

Lead Sponsor:

Solvay Pharmaceuticals

Treatments:

Pancreatin
Pancrelipase